Status:
COMPLETED
Assessment of in Vivo Skeletal Muscle Viscoelasticity (ARFI Imaging) With Aging and Cancer
Lead Sponsor:
University Hospital, Bordeaux
Conditions:
Sarcopenia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Sarcopenia is known to be associated with loss in muscle mass that results from a reduced number of muscle fibres, an atrophy of remaining muscle fibres, and an increased infiltration of non-contracti...
Eligibility Criteria
Inclusion
- Men or women 18 years old or more,
- Able to understand the protocol and to give their written consent,
- Health insurance.
- Specific inclusion criteria:
- Group A: volunteers 18 to 30 yrs; without any pathology,
- Group B: volunteers ≥ 70 yrs; without any pathology,
- Group C: Performance status (ECOG) \< 4; patients included in CAPADOGE study presenting curative cares for cancer by chemotherapy and/ or surgery and/or hormonotherapy and/or radiotherapy.
Exclusion
- Intense activity in 7 preceding days,
- Functional dependency,
- under a legal protection.
- Specific non-inclusion criteria:
- Groups A \& B: serious chronic disease,
- Group C: Palliative care.
Key Trial Info
Start Date :
November 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2014
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT01484821
Start Date
November 1 2011
End Date
October 1 2014
Last Update
January 13 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Bordeaux - Hôpital Saint André
Bordeaux, France, 33000
2
CHU de Bordeaux - Hôpital Haut-Lévêque
Pessac, France, 33600